Evidence map›Paper›PMID 36560581›Full record

ArticleVaccines2022

Ag85a-S2 Activates cGAS-STING Signaling Pathway in Intestinal Mucosal Cells.

Sheng Dang, Wanyang Li, Shubo Wen, Yang Song, Meirong Bai, Shuyan Li, Zeliang Chen, Jingbo Zhai

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. An SNP-based diagnostic method forFrontiers in veterinary science · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sheng DangInnovative Institute of Zoonoses, Inner Mongolia Minzu University, Tongliao 028000, China.
Wanyang LiInnovative Institute of Zoonoses, Inner Mongolia Minzu University, Tongliao 028000, China.
Shubo WenInnovative Institute of Zoonoses, Inner Mongolia Minzu University, Tongliao 028000, China.
Yang SongInnovative Institute of Zoonoses, Inner Mongolia Minzu University, Tongliao 028000, China.
Meirong BaiInnovative Institute of Zoonoses, Inner Mongolia Minzu University, Tongliao 028000, China.
Shuyan LiInnovative Institute of Zoonoses, Inner Mongolia Minzu University, Tongliao 028000, China.
Zeliang ChenInnovative Institute of Zoonoses, Inner Mongolia Minzu University, Tongliao 028000, China.
Jingbo ZhaiInnovative Institute of Zoonoses, Inner Mongolia Minzu University, Tongliao 028000, China.ORCID 0000-0001-8891-279X
Inner Mongolia University for Nationalities · CN

Funding

Brucellosis Prevention and Treatment Engineering Technology Research Center of Mongolia Autonomous region open issue MDK2018053Key Laboratory of Mongolian Medicine Research and Development Engineering, Ministry of Education open issue MDK2021040Major science and technology projects of Inner Mongolia of China 2019ZD006National Natural Science Foundation of China 82160312
6 · The paper itself

Abstract

Brucellosis is a zoonotic disease caused by Gram-negative bacteria. Most of the brucellosis vaccines in the application are whole-bacteria vaccines. Live-attenuated vaccines are widely used for brucellosis prevention in sheep, goats, pigs, and cattle. Thus, there is also a need for an adjuvanted vaccine for human brucellosis, because the attenuated

Indexed as

Ag85aBrucellabrucellosis

Identifiers

PMID36560581
PMCPMC9785823
OpenAlexW4312211949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.